| Literature DB >> 31159321 |
Lidia García-Quiles1, Arantzazu Valdés2, Ángel Fernández Cuello3, Alfonso Jiménez4, María Del Carmen Garrigós5, Pere Castell6.
Abstract
Polyhydroxyalkanoates (PHAs) are nowadays considered competent candidates to replace traditional plastics in several market sectors. However, commercial PHA materials exhibit unsatisfactory smells that can negatively affect the quality of the final product. The cause of this typical rancid odour is attributed to oxidized cell membrane glycolipids, coming from Gram-negative production strains, which remain frequently attached to PHAs granules after the extraction stage. The aim of this research is the development of customised PHA bio-nano-composites for industrial applications containing organomodified nanoclays with high adsorbance properties able to capture volatile compounds responsible for the displeasing fragrance. To this end, a methodology for the detection and identification of the key volatiles released due to oxidative degradation of PHAs has been established using a headspace solid-phase microextraction technique. We report the development of nine bio-nano-composite materials based on three types of commercial PHA matrices loaded with three species of nanoclays which represent a different polar behaviour. It has been demonstrated that although the reached outcoming effect depends on the volatile nature, natural sepiolite might result in the most versatile candidate for any the PHA matrices selected.Entities:
Keywords: autoxidation; bio-nanocomposites; biopolymers; extrusion-compounding; headspace solid phase microextraction; microstructure; nanoclays; polyhydroxyalkanoates; scanning electron microscope; thermal gravimetric analysis; thermal properties; volatiles
Year: 2019 PMID: 31159321 PMCID: PMC6631169 DOI: 10.3390/polym11060945
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Summary of material formulations. Table reproduced with permission of García-Quiles et al. [30].
| Material Formulation | Commercial Matrix Used | Nature of the PHA | Type of Reinforcement (3 wt %) |
|---|---|---|---|
| PHA1005 | PHA1005 (Metabolix) | P3HB- | (3HB- |
| PHA1005_T1 | PHA1005 (Metabolix) | P3HB- | T1: Aminosilane Sepiolite |
| PHA1005_T2 | PHA1005 (Metabolix) | P3HB- | T2: Natural Sepiolite |
| PHA1005_T3 | PHA1005 (Metabolix) | P3HB- | T3: Sodium Montmorillonite-quaternary ammonium salt |
| PHA3002 | PHA3002 (Metabolix) | P3HB- | (3HB- |
| PHA3002_T1 | PHA3002 (Metabolix) | P3HB- | T1: Aminosilane Sepiolite |
| PHA3002_T2 | PHA3002 (Metabolix) | P3HB- | T2: Natural Sepiolite |
| PHA3002_T3 | PHA3002 (Metabolix) | P3HB- | T3: Sodium Montmorillonite-quaternary ammonium salt |
| PHB226 | PHB226 (Biomer) | P3HB | Traces of PBA and plasticizer found, & Talc |
| PHB226_T1 | PHB226 (Biomer) | P3HB | T1: Aminosilane Sepiolite |
| PHB226_T2 | PHB226 (Biomer) | P3HB | T2: Natural Sepiolite |
| PHB226_T3 | PHB226 (Biomer) | P3HB | T3: Sodium Montmorillonite-quaternary ammonium salt |
Box-Benkhen experimental design proposed for the headspace solid-phase microextraction (HS-SPME) optimization procedure.
| Run | Temperature (°C) | Time (min) | NaCl (1 M) |
|---|---|---|---|
| 1 | 70 | 37.5 | 0.5 |
| 2 | 50 | 60 | 0.5 |
| 3 | 90 | 60 | 0.5 |
| 4 | 70 | 60 | 0 |
| 5 | 90 | 15 | 0.5 |
| 6 | 70 | 15 | 1 |
| 7 | 70 | 37.5 | 0.5 |
| 8 | 90 | 37.5 | 0 |
| 9 | 90 | 37.5 | 1 |
| 10 | 70 | 15 | 0 |
| 11 | 50 | 37.5 | 1 |
| 12 | 70 | 37.5 | 0.5 |
| 13 | 50 | 37.5 | 0 |
| 14 | 70 | 60 | 1 |
| 15 | 50 | 15 | 0.5 |
| 16 | 70 | 37.5 | 0.5 |
Figure 1SEM micrographs of nanoclays (a–c); neat matrices (d,k,l) and composites: PHA1005 composites (e–g), PHA3002 composites (i–k); PHB226 composites (m–o).
Thermal results obtained by TGA. Tonset %, Tmax %, and T50 % represent the temperature of the initial degradation, the maximum degradation rate of decomposition, and 50 wt % loss of the samples, respectively. FR represents the final residue and DTG first derivative.
| Materials | Tonset [°C] | Tmax [°C] | T50 wt % [°C] | FR [%] | ||
|---|---|---|---|---|---|---|
| PHA1005 | 268.13 | 278.33 | 279.62 | 9.45 | ||
| PHA1005_T1 | 267.94 | 275.51 | 278.89 | 12.93 | ||
| PHA1005_T2 | 265.75 | 278.33 | 278.52 | 13.56 | ||
| PHA1005_T3 | 263.20 | 278.33 | 277.25 | 13.27 | ||
| PHA3002 | 290.01 | 307.67 | 305.34 | 8.39 | ||
| PHA3002_T1 | 287.46 | 307.67 | 305.61 | 11.71 | ||
| PHA3002_T2 | 283.63 | 302.33 | 300.23 | 10.93 | ||
| PHA3002_T3 | 284.73 | 299.67 | 298.95 | 11.26 | ||
| PHB226 | 275.97 | 386.87 | 297.00 | 403.70 | 293.84 | 2.73 |
| PHB226_T1 | 283.63 | 384.31 | 299.82 | 411.67 | 301.50 | 5.61 |
| PHB226_T2 | 278.52 | 383.03 | 297.00 | 407.30 | 296.40 | 5.83 |
| PHB226_T3 | 272.14 | 347.29 | 291.49 | 382.86 | 287.46 | 6.37 |
Figure 2TGA curves: (a) neat matrices and nanoclays; (b) PHA1005 composites; (c) PHA3002 composites; (d) PHB226 composites.
Figure 3TIC chromatogram obtained for PHB 226 sample under run 3 of the BBD. * Time refers to s.
Figure 4Pareto charts of factors and interactions obtained from the BBD for the sum of the volatile compounds. The vertical line indicates the statistical significance at 5% of the effects.
Volatile compounds content for the PHB 226 PHA 1005 and PHA 3002 controls and the T1, T2 and T3 formulations, expressed as the mean ± SD (n = 3).
| Volatile Compound | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Material | 1-Hexanol | Heptanal | Octanal | Decanal | α-Methylstyrene | Benzaldehyde | ||||||
| Average | SD | Average | SD | Average | SD | Average | SD | Average | SD | Average | SD | |
| (μg/g sample) | (μg/g sample) | (μg/g sample) | (μg/g sample) | (μg/g sample) | (μg/g sample) | |||||||
| PHA 1005 | 18.8 | 3.8 | 14.8 | 6.8 | 68.6 | 14.9 | 900 | 500 | 102.8 | 35.4 | 6.4 | 0.3 |
| PHA 1005_T1 | 13.2 | 1.1 | 15.8 | 1.5 | 68.1 | 7.1 | 2100 | 500 | 283.6 | 12.2 | 5.7 | 1.2 |
| PHA 1005_T2 | 8.2 | 1.3 | 15.3 | 3.2 | 78.1 | 13.9 | 1300 | 200 | 25.7 | 10.0 | 4.3 | 0.3 |
| PHA 1005_T3 | 5.3 | 0.7 | 81.2 | 29.3 | 5.3 | 0.7 | 5300 | 700 | 89.6 | 33.5 | 5.3 | 0.7 |
| PHA 3002 | 2.7 | 1.0 | 18.8 | 10.0 | 75.4 | 18.8 | 1000 | 300 | 135.4 | 28.4 | 4.5 | 1.5 |
| PHA 3002_T1 | 2.8 | 1.0 | 27.9 | 1.7 | 41.2 | 6.5 | 3300 | 500 | 279.5 | 17.6 | 7.1 | 0.3 |
| PHA 3002_T2 | 16.6 | 2.9 | 41.4 | 16.3 | 25.3 | 7.4 | 2400 | 400 | 59.3 | 11.6 | 4.6 | 0.7 |
| PHA 3002_T3 | 8.1 | 2.7 | 98.8 | 11.1 | 53.6 | 16.8 | 1800 | 400 | nd | nd | 6.7 | 1.1 |
| PHB 226 | 3.7 | 0.9 | 4.0 | 0.6 | 26.7 | 0.5 | 2300 | 100 | 40.4 | 4.6 | 7.7 | 0.7 |
| PHB 226_T1 | 1.2 | 0.9 | 3.2 | 1.1 | 32.6 | 6.0 | 1900 | 200 | 43.4 | 7.1 | 7.2 | 2.6 |
| PHB 226_T2 | 2.3 | 0.6 | 10.3 | 0.9 | 39.3 | 7.7 | 1300 | 300 | 10.3 | 2.3 | 4.9 | 0.5 |
| PHB 226_T3 | 1.6 | 0.6 | 3.5 | 7.6 | 71.3 | 17.9 | 2800 | 700 | 39.6 | 17.3 | 6.5 | 2.7 |
nd = no data.
Figure 5Percentage variation of volatile substances in the samples of study: (a) PHA1005, (b) PHA3002, (c) PHB226.
Summary of the organoclay that works best to reduce the release of the volatile compounds studied for each polymer matrix.
| Volatile | PHA 1005 | PHA 3002 | PHB 226 | ||
|---|---|---|---|---|---|
| 1-Hexanol | T3 | T1 | T1 | ||
| Heptanal | T2 | T1 | T1 | ||
| Octanal | T3 | T2 | T1 | ||
| Decanal | T2 | T3 | T2 | ||
| α-Methylstyrene | T2 | T3 | T2 | ||
| Benzaldehyde | T2 | T2 | T2 |